Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04130542
Title Phase 1 Trial of LVGN6051 as Single Agent and in Combination Therapy in Advanced or Metastatic Malignancy
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Lyvgen Biopharma Holdings Limited
Indications

Advanced Solid Tumor

hematologic cancer

Therapies

LVGN6051

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.